Novozymes and Chr. Hansen Merge to Form Novonesis: A Global Biosolutions Powerhouse with €3.7 Billion Annual Revenue
The world’s largest provider of microbial technologies and enzymes, Novozymes, and Chr. Hansen, a bioscience supplier, have successfully merged to form Novonesis, a global partner for multiple industries, creating biosolutions for better lives and a healthier planet. The Danish merger — reportedly the largest ever in the country — was finalized following the final registration with the Danish Business Authority. According to the announcement, the combined group will have annual revenue of approximately …